Prognostic Indicators of Overall Survival in Hepatocellular Carcinoma Patients Undergoing Liver Resection
Cancers · 07.04.2024 · 16 (7) · 1427
DOI: 10.3390/cancers16071427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 07.04.2024. Verfasst von Cristina-Paula Ursu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, "Iuliu Hațieganu" University of Medicine and Pharmacy, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Iuliu Hațieganu" University of Medicine and Pharmacy Cluj-Napoca, Romania, Doctoral Re-search Program, "New smart and adaptive robotics solutions for personalized minimally invasive surgery in cancer treatment-ATHENA", funded by the European Union- NextGeneratio…, “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Doctoral Re-search Program.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the predominant form of primary liver cancer and the third contributor to malignancy-related deaths worldwide. The hepatic venous pressure gradient (HVPG), transient elastography-liver stiffness measurement (TE-LSM), and the association between TBS (tumor burden score), alpha-fetoprotein levels, and the Child–Pugh classification (TAC score) can serve as valuable prognostic indicators for these patients. Therefore, the main objective of our research was to analyze the prognostic value of the HVPG, TE-LSM, TBS, and TAC scores. An observational and survival study was conducted on 144 subjects. Our findings indicated that HVPG greater than 10 mmHg, AFP surpassing 400 ng/mL, an advanced C–P class, and low TAC score are independent predictors of overall survival. During the multivariate analysis, AFP serum levels and C–P class proved statistically significant. The present study revealed significant differences in overall survival between the two groups divided upon HVPG values and settled by the cutoff of 10 mmHg (p = 0.02). Moreover, by dividing the cohort into three groups based on the TAC score (very low, low, and moderate), statistically significant differences in overall survival were observed across the groups (p = 0.004).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, "Iuliu Hațieganu" University of Medicine and Pharmacy, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania.
- "Prof. Dr. Octavian Fodor" Regional Institute of Gastroenterology and Hepatology, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania.
- Department of Surgery-Practical Abilities, "Iuliu Hațieganu" University of Medicine and Pharmacy, Marinescu Street, No. 23, 400337 Cluj-Napoca, Romania.
- Romanian Society of Medical Informatics, 300041 Timișoara, Romania.
- Department of Community Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, Avram Iancu Street, No. 31, 400347 Cluj-Napoca, Romania.
- Department of Internal Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania.
ORCID-Profile: Cristina-Paula Ursu, Ștefan Ursu, Ariana-Anamaria Cordoș, Dan Vălean, Horia Ștefănescu, Florin Graur
Förderung
- "Iuliu Hațieganu" University of Medicine and Pharmacy Cluj-Napoca, Romania, Doctoral Re-search Program
- "New smart and adaptive robotics solutions for personalized minimally invasive surgery in cancer treatment-ATHENA", funded by the European Union- NextGeneratio…
- “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Doctoral Re-search Program
- European Union— NextGenerationEU and Romanian Government under National Recovery and Resilience Plan for Romania
Zitieren
APA
Ursu, C. P., Ciocan, A., Ursu, Ș., Ciocan, R. A., Gherman, C. D., Cordoș, A. A., Vălean, D., Pop, R. S., Furcea, L. E., Procopeț, B., Ștefănescu, H., Moiș, E. I., Al Hajjar, N., & Graur, F. (2024). Prognostic Indicators of Overall Survival in Hepatocellular Carcinoma Patients Undergoing Liver Resection. Cancers, 16(7), 1427. https://doi.org/10.3390/cancers16071427
Vancouver
Ursu CP, Ciocan A, Ursu Ș, Ciocan RA, Gherman CD, Cordoș AA, et al. Prognostic Indicators of Overall Survival in Hepatocellular Carcinoma Patients Undergoing Liver Resection. Cancers. 2024;16(7):1427. doi:10.3390/cancers16071427
BibTeX
@article{Ursu2024,
author = {Ursu, Cristina-Paula and Ciocan, Andra and Ursu, Ștefan and Ciocan, Răzvan Alexandru and Gherman, Claudia Diana and Cordoș, Ariana-Anamaria and Vălean, Dan and Pop, Rodica Sorina and Furcea, Luminița Elena and Procopeț, Bogdan and Ștefănescu, Horia and Moiș, Emil Ioan and Al Hajjar, Nadim and Graur, Florin},
title = {Prognostic Indicators of Overall Survival in Hepatocellular Carcinoma Patients Undergoing Liver Resection},
journal = {Cancers},
year = {2024},
volume = {16},
number = {7},
pages = {1427},
doi = {10.3390/cancers16071427}
}
EUVIMED